These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26744837)

  • 1. Endothelial and Smooth Muscle Cell Interactions in the Pathobiology of Pulmonary Hypertension.
    Gao Y; Chen T; Raj JU
    Am J Respir Cell Mol Biol; 2016 Apr; 54(4):451-60. PubMed ID: 26744837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathology and pathobiology of pulmonary hypertension.
    Guignabert C; Dorfmuller P
    Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial cell dysfunction and cross talk between endothelium and smooth muscle cells in pulmonary arterial hypertension.
    Humbert M; Montani D; Perros F; Dorfmüller P; Adnot S; Eddahibi S
    Vascul Pharmacol; 2008; 49(4-6):113-8. PubMed ID: 18606248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathobiology of pulmonary hypertension. Endothelium.
    Tuder RM; Cool CD; Yeager M; Taraseviciene-Stewart L; Bull TM; Voelkel NF
    Clin Chest Med; 2001 Sep; 22(3):405-18. PubMed ID: 11590837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension.
    Ma C; Li Y; Ma J; Liu Y; Li Q; Niu S; Shen Z; Zhang L; Pan Z; Zhu D
    Hypertension; 2011 Oct; 58(4):679-88. PubMed ID: 21859965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular pathobiology of pulmonary arterial hypertension.
    Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels.
    Michelakis ED; Weir EK
    Clin Chest Med; 2001 Sep; 22(3):419-32. PubMed ID: 11590838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of hypoxia on the cells of the pulmonary vasculature.
    Pak O; Aldashev A; Welsh D; Peacock A
    Eur Respir J; 2007 Aug; 30(2):364-72. PubMed ID: 17666559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension.
    Perros F; Ranchoux B; Izikki M; Bentebbal S; Happé C; Antigny F; Jourdon P; Dorfmüller P; Lecerf F; Fadel E; Simonneau G; Humbert M; Bogaard HJ; Eddahibi S
    J Am Coll Cardiol; 2015 Feb; 65(7):668-80. PubMed ID: 25677428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
    Berg JT
    J Appl Physiol (1985); 2007 Oct; 103(4):1455. PubMed ID: 17916681
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension.
    Frank DB; Abtahi A; Yamaguchi DJ; Manning S; Shyr Y; Pozzi A; Baldwin HS; Johnson JE; de Caestecker MP
    Circ Res; 2005 Sep; 97(5):496-504. PubMed ID: 16100039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular remodeling in neonatal pulmonary hypertension. Role of the smooth muscle cell.
    Stenmark KR; Orton EC; Reeves JT; Voelkel NF; Crouch EC; Parks WC; Mecham RP
    Chest; 1988 Mar; 93(3 Suppl):127S-133S. PubMed ID: 3342691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathobiology of pulmonary hypertension. Extracellular matrix.
    Rabinovitch M
    Clin Chest Med; 2001 Sep; 22(3):433-49, viii. PubMed ID: 11590839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of hemodynamics in pulmonary vascular remodeling: implications for primary pulmonary hypertension.
    Botney MD
    Am J Respir Crit Care Med; 1999 Feb; 159(2):361-4. PubMed ID: 9927344
    [No Abstract]   [Full Text] [Related]  

  • 15. Activation of Calpain-2 by Mediators in Pulmonary Vascular Remodeling of Pulmonary Arterial Hypertension.
    Kovacs L; Han W; Rafikov R; Bagi Z; Offermanns S; Saido TC; Black SM; Su Y
    Am J Respir Cell Mol Biol; 2016 Mar; 54(3):384-93. PubMed ID: 26248159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular interplay in pulmonary arterial hypertension: implications for new therapies.
    Nogueira-Ferreira R; Ferreira R; Henriques-Coelho T
    Biochim Biophys Acta; 2014 May; 1843(5):885-93. PubMed ID: 24491811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension.
    Taraseviciene-Stewart L; Kasahara Y; Alger L; Hirth P; Mc Mahon G; Waltenberger J; Voelkel NF; Tuder RM
    FASEB J; 2001 Feb; 15(2):427-38. PubMed ID: 11156958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of structural remodeling in chronic pulmonary hypertension.
    Durmowicz AG; Stenmark KR
    Pediatr Rev; 1999 Nov; 20(11):e91-e102. PubMed ID: 10551895
    [No Abstract]   [Full Text] [Related]  

  • 19. The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting.
    Qi J; Du J; Tang X; Li J; Wei B; Tang C
    Heart Vessels; 2004 Mar; 19(2):81-8. PubMed ID: 15042392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal Mechanisms of Vascular Remodeling in the Development of Pulmonary Arterial Hypertension.
    Li MX; Jiang DQ; Wang Y; Chen QZ; Ma YJ; Yu SS; Wang Y
    J Cardiovasc Pharmacol; 2016 Feb; 67(2):182-90. PubMed ID: 26448276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.